Anteo Diagnostics secures funding for PoC platform project

Company News

by Jessica Ellerm


Anteo Diagnostics Limited (ASX:ADO) has announced it has secured funding to further the technology readiness of Planet Innovation’s Point of Care platform.

Alongisde Planet Innovation, Anteo is partnering with Deakin University and the Defence Materials Technology Centre to ready the platform.

Anteo will provide Planet Innovation’s parent company Nplex with a commercial solution to the challenges of controlling the surface between synthetic materials and biological reagents.

The company has noted commercialization is beyond the scope of the 12 month project.

Anteo Diagnostics Limited reported a net loss of $5.97 million at 30 June 2016.
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.